| Visualizaciones | |
|---|---|
| Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. | 246 |
| mayo 2024 | junio 2024 | julio 2024 | agosto 2024 | septiembre 2024 | octubre 2024 | noviembre 2024 | |
|---|---|---|---|---|---|---|---|
| Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. | 4 | 2 | 3 | 1 | 0 | 2 | 0 |
| Visualizaciones | |
|---|---|
| Trials.pdf | 255 |
| Visualizaciones | |
|---|---|
| México | 67 |
| Estados Unidos | 44 |
| Rusia | 16 |
| Canadá | 6 |
| Argentina | 5 |
| Brasil | 5 |
| Reino Unido | 4 |
| Irán | 4 |
| Francia | 3 |
| Perú | 3 |
| Visualizaciones | |
|---|---|
| Mexico | 44 |
| Saint Petersburg | 12 |
| Oakland | 8 |
| Toluca | 8 |
| Palo Alto | 4 |
| Secaucus | 4 |
| Fairfield | 3 |
| Houston | 3 |
| Jacksonville | 3 |
| Lima | 3 |